ASCO Releases Guideline on Addressing Osteoporosis Risk With Nonmetastatic Cancer
The guideline includes strategies to identify patients with nonmetastatic cancer who may be at a higher risk for osteoporotic fractures
Osteoporosis
Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
Osteoporosis medications were found to reduce bone mineral density loss and risk of fracture in men with nonmetastatic prostate cancer being treated with androgen-deprivation therapy.
Male smokers at increased risk for osteoporosis, fractures
Among middle-aged to elderly tobacco smokers, men were more likely than women to have osteoporosis and vertebral fractures.
Paroxetine and chemoprevention drugs
Can the drug paroxetine mesylate (Brisdelle, Paxil) be given to patients taking a chemoprevention drug such as raloxifene (Evista) or any of the aromatase inhibitors?
Biomarkers may predict who will respond to breast cancer prevention therapy
Single nucleotide polymorphisms (SNPs) in or near the genes ZNF423 and CTSO were associated with breast cancer risk among women who underwent prevention therapy with tamoxifen and raloxifene.
USPSTF recommends tamoxifen, raloxifene for women at risk of breast cancer
The U.S. Preventive Services Task Force recommends that women who are at increased risk of primary breast cancer consider taking preventive medications such as tamoxifen.
Steroid-induced osteoporotic fracture
Reviews steroid-induced ostoporotic fracture and its management
- Loading...
Loading...
Loading... 
Loading...